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BACKGROUND: Identification of high-grade meningiomas in preoperative magnetic resonance imaging (MRI) is
important for optimized surgical strategy and best possible resection. Numerous studies investigated subjectively
determinedmorphological features as predictors of tumor biology inmeningiomas. The aim of this studywas to identify
the predictive value of more reliable, quantitativelymeasured signal intensities inMRI for differentiation of high- and low-
grade meningiomas and identification of meningiomas with high proliferation rates, respectively. PATIENTS AND
METHODS: Sixty-six patients (56 World Health Organization [WHO] grade I, 9 WHO grade II, and 1 WHO grade I) were
included in the study. PreoperativeMRI signal intensities (fluid-attenuated inversion recovery [FLAIR], T1 precontrast, and
T1 postcontrast as genuine and normalized values) were correlated with Ki-67 expression in tissue sections of resected
meningiomas. Differences between the groups (analysis of variance) and Spearman rho correlation were computed
using SPSS 22. RESULTS: Mean values of genuine signal intensities of meningiomas in FLAIR, T1 native, and T1
postcontrast were 323.9 ± 59, 332.8 ± 67.9, and 768.5 ± 165.3. Mean values of normalized (to the contralateral white
matter) signal intensities of meningiomas in FLAIR, T1 native, and T1 postcontrast were 1.5 ± 0.3, 0.8 ± 0.1, and 1.9 ±
0.4. There was no significant correlation between MRI signal intensities and WHO grade or Ki-67 expression. Signal
intensities did not differ significantly between WHO grade I and II/III meningiomas. Ki-67 expression was significantly
increased in high-grademeningiomas comparedwith low-grademeningiomas (P b 0.01). Objectivelymeasured values of
MRI signal intensities (FLAIR, T1 precontrast, and T1 postcontrast enhancement) did not distinguish between high-grade
and low-grademeningiomas. Furthermore, therewasnoassociationbetweenMRI signal intensities andKi-67expression
representing proliferative activity.
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http://dx.doi.org/10.1016/j.tranon.2016.05.003Meningiomas are among the most common brain tumors. Their
incidence is about 1%, and they account for almost one third of all
primary intracranial masses. The majority of meningiomas are very
slowly growing and nonsymptomatic or minimally symptomatic
entities, discovered as incidental findings on neuroimaging [1]. The
World Health Organization (WHO) classification system distin-
guishes 3 histological grades and 15 subtypes and is a well-accepted
tool for prediction of prognosis. Although most meningiomas are
benign masses, certain histological subtypes reveal very high
recurrence rates despite the tumors’ seemingly total removal. Grade
II (atypical) and grade III (anaplastic) meningiomas are associatedwith an increased risk of recurrence, are more aggressive, and show
invasive behavior [2]. Grade I meningiomas are generally considered
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deficits and impaired long-term survival due to tumor recurrence and
stroke despite their low histopathological grading in a considerable
proportion of cases [3,4]. Increased mitotic activity (more than 4
mitoses per 10 high-power fields) and elevated Ki-67 expression
(Ki-67 index of more than 5% of nuclei) are reliable histopathological
markers for tumor recurrence [2].
Because histopathological grading alone does not predict outcome
satisfyingly, numerous studies investigated the value of preoperative
magnetic resonance imaging (MRI) for prognostics. For example, Liu et
al. demonstrated that hyperintensity on diffusion-weighted imaging,
heterogeneous gadolinium enhancement, disruption of the arachnoid at
brain tumor interface, T2 hyperintense peritumoral edema, and irregular
tumor shape were independent predictors of non–grade I meningioma
[5]. Other works produced comparable results, although some of these
studies underline the importance of positive capsular enhancement [6,7],
whereas others emphasize the predictive value of peritumoral edema [5,8].
All the above-cited works investigated morphological features of
meningiomas summarized in subjective scoring systems, but not one of
the studies objectively analyzed values of SIs in commonly used
preoperative MRI sequences.
Therefore, the aim of this study was to investigate the predictive value
of genuine and normalized SIs of standardized preoperativeMRI (T1 pre-
and postcontrast, T2, and fluid-attenuated inversion recovery [FLAIR]) as
in vivo predictors of proliferative activity of meningiomas.
Material and Methods
This study was approved by the institutional review board (Martin
Luther University Ethics Committee).
Patients
Overall, 66 patients with different meningiomas were included
into the retrospective analysis. There were 50 women and 16 men
with a mean age of 59.7 ± 15.8 years. In 56 patients (approximately
84.8%), WHO grade I tumors were diagnosed. Most frequently,
meningothelial meningiomas (n = 32,) followed by transitional (n =
12), fibroblastic (n = 7), angiomatous (n = 4), and psammomatous
(n = 1) subtypes were identified. Grade II tumors were identified in
9 cases (13.6%) and grade III in 1 (1.5%).
MRI
In all patients, cranial MRI was performed using a 1.5-T device
(Magnetom Vision Sonata Upgrade, Siemens, Erlangen, Germany).
The imaging protocol included the following sequences:
1. Axial T2-weighted (T2w) fluid-attenuated inversion recovery (FLAIR)
sequence (repetition time/echo time: 8000/129, slice thickness: 5mm,
acquisition matrix: 256 × 256, field of view: 230 mm);
2. Axial and coronal T1-weighted (T1w) spin echo sequences (repetition
time/echo time: 562/16, slice thickness: 5 mm, acquisition matrix:
256 × 256, field of view: 230 mm) before and after intravenous
application of contrast medium (gadopentate dimeglumine, Magne-
vist, Bayer Schering Pharma, Leverkusen, Germany).
All images were available in digital form and were analyzed by one
radiologist (A. S., 14 years of radiological experience) on a PACS
workstation (Centricity PACS, GE Medical Systems, Milwaukee, WI).
The slices with the largest diameter of each tumor were selected for
signal intensity (SI) calculation. In every case, a polygonal region of
interest (ROI) as large as possible was manually drawn onpostcontrast T1w images. Every ROI was automatically placed also
on all other images (T2w and precontrast T1w). Cystic and necrotic
areas as well as large vessels of the tumors were not considered for
evaluation. In all images, mean SI values were estimated. Further-
more, ROIs were drawn in the normal white matter of the
contralateral hemisphere (SI white matter). Normalized SI was
calculated in every case as the ratio SI meningioma/SI white matter.
In addition, for each lesion, the ratio SI on postcontrast T1w/SI on
precontrast T1w was calculated (SI contrast). Figures 1 and 2, a–c,
exemplarily show axial images (FLAIR, T1 precontrast, T1
postcontrast) of WHO grade I (transitional) and WHO grade II
(atypical) meningiomas.
Histopathology and Immunohistochemistry
All included meningiomas were surgically resected and histopath-
ologically analyzed. Tumor grading was classified according to the
WHO [2].
In every case, the proliferation index was estimated on Ki-67
antigen-stained specimens by using MIB-1 monoclonal antibody
(DakoCytomation, Denmark) as reported previously [9]. Two
high-power fields (0.16 mm2 per field, ×400) were analyzed. The area
with the highest number of positive tumor nuclei was selected. Figures 1d
and 2d exemplarily show Ki-67 immunostaining of WHO grade I
(transitional) and WHO grade II (atypical) meningiomas.
Statistical Analysis
Statistical analysis was performed using SPSS Version 22.
Differences between groups were assessed using one-way analysis of
variance. Correlations between Ki-67 expression and genuine or
normalized SIs, respectively, were calculated using a Spearman rho
correlation. Significance level was set to .05.
Results
MR SIs (T1 precontrast, FLAIR, T1 postcontrast, and normalized
SIs) of the investigated grade I to III meningiomas and Ki-67
expression (%) are shown in Table 1.
One-way analysis of variance did not show significant differences
between meningiomas of WHO grade I, II, or III regarding their MRI
SIs. The difference in Ki-67 expression achieved statistical significance
(P b .01) between low-grade and high-grademeningiomas. Figure 3, a–h,
summarize the relation of MRI SIs and Ki-67 expression betweenWHO
grade I and WHO grade II/III meningiomas. For reasons of simplicity
and clarity, high-grade meningiomas (grade II and III meningiomas) are
displayed together and compared with grade I meningiomas.
No correlation was found between MRI SIs and Ki-67
expression. Table 2 displays results of statistical analysis of the correlation
between SIs (genuine and normalized) and Ki-67 expression.
Discussion
We investigated in meningiomas the relationship between objectively
measurable SIs on standard preoperativeMRI and the proliferative activity
in histopathology. Expression of the proliferation associated antigen Ki-67
was significantly higher in grade II and III meningiomas, but there was
neither a significant difference of MRI SIs among grade I, II, or III
meningiomas nor a correlation between Ki-67 expression and MRI SIs.
Preoperative MRI is a valuable tool for identification and follow-up
of meningiomas with aggressive behavior in the clinical routine.
High-grade meningiomas are a significant cause of morbidity
and mortality and need to be identified prior to surgery to achieve
the best resection. Numerous studies investigated morphological
Figure 1. (a–d) Imaging findings (FLAIR, T1 precontrast, T1 postcontrast) and Ki-67 staining of a WHO grade I meningioma. Signal
intensities were as follows: normalized FLAIR SI = 1.47, normalized precontrast T1 SI = 0.81, normalized postcontrast SI = 1.77, and
postcontrast SI/precontrast SI = 2.24. Ki-67 index = 3%.
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predict invasiveness and increased risk of recurrence [5–8,10,11].
Consensually, peritumoral edema, ill-defined tumor margins,
heterogeneous contrast enhancement, and absence of a subarach-
noidal rim surrounding the tumor are important indicators of non–
grade I meningiomas with aggressive tumor growth, high recurrence
risk, and a tendency of infiltration of surrounding parenchyma.
Nevertheless, these are subjective criteria only describing morpho-
logical features. Interobserver and intraobserver variability signifi-
cantly reduces the reliability of these prediction models [6].
Previously, few studies investigated imaging parameters semiquanti-
tatively and their relationship to histopathological features with at
least partially contradictory findings. In earlier years Maiuri and
coworkers [12] analyzed T1 and T2 SIs (clinically applied as
categories of hypointensity, isointensity, and hyperintensity) in
meningiomas and found that T1w images may predict the presence
of cysts and intratumoral blood vessels, whereas T2w images may beable to give information about histological subtype, vascularity, and
consistency. More recently, Hadidy and colleagues examined the
association between SI on T1w and T2w FLAIR MRI (with very
approximate categories of hypointensity, isointensity, andhyperintensity) as
well as contrast enhancement patterns and histopathological grading [13]
and found no correlation between MRI and histopathology. Besides these
studies, other authors investigated the association between cellularity, Ki-67
expression, and different apparent diffusion coefficient fractions in
low-grade and high-grade meningiomas and were able to show that
apparent diffusion coefficient mean is able to distinguish between grade I
and grade II/III meningiomas [14]. To the best of our knowledge, no
further studies exist that investigated the correlation between objectively
measurable, numeric MRI SIs and histopathological features, especially
Ki-67 expression representing proliferative activity.
This study clarifies that even numerically quantified SIs ofmeningiomas
in preoperative MRI cannot distinguish between low-grade, noninvasive
meningiomas and high-grade, aggressive-invasive meningiomas.
Figure 2. (a–d) Imaging findings (FLAIR, T1precontrast, T1 postcontrast) and Ki-67 staining of a WHO grade II (atypical) meningioma.
Signal intensities were as follows: normalized FLAIR SI = 1.45, normalized T1 precontrast SI = 0.87, normalized postcontrast SI = 1.88,
and postcontrast SI/precontrast SI = 1.97. Ki-67 index = 18%.
able 1.MRI SIs Displayed as Genuine and Normalized Values (SI of the Respective Meningioma‚
’, Divided by the SI of the Unaffected Contralateral White Matter ‚wm’) and Ki-67 Expression of
ll Investigated Meningiomas
Mean ± SD Median Range
1 meningioma 332.8 ± 67.9 324 197-500
1 white matter 407.2 ± 63.5 411 276-600
1 m/wm 0.8 ± 0.1 0.8 0.6-1.0
LAIR meningioma 323.9 ± 59 317 200-495
LAIR white matter 211.5 ± 26.8 210 145-285
LAIR m/wm 1.5 ± 0.3 1.5 1.0-2.5
1 postcontrast meningioma 768.5 ± 165.3 764 512-1300
1 postcontrast white matter 407.7 ± 67.6 413.5 256-630
1 pos contrast m/wm 1.9 ± 0.4 1.9 1.1-2.9
1 postcontrast m/wm
T1 native m/wm
2.3 ± 0.4 2.3 1.7-3.5
i-67 expression % 5.2 ± 5.3 3 1-20
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comparatively small.
Conclusion
To optimize surgical therapy, it is necessary to identify aggressive and
invasivemeningiomas on preoperativeMRI.Numerous subjective scoring
systems have been developed on the basis of morphological features of
meningiomas inMRI to separate high-grade from low-grademeningiomas
with varying sensitivities. This is the first study that investigated the value
of objectively measured, quantified SIs as predictors of aggressive tumor
behavior. Counterintuitively, quantitatively measured SIs of standardized
preoperative MRI were not able to differentiate low -from high-grade
meningiomas or to identify meningiomas with a high proliferative activity.
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Figure 3. (a–h) Box plots give an overview on the relation of MRI SI (a–g) and Ki-67 index between low-grade and high-grade
meningiomas.
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Table 2. Statistical Correlations between Genuine and Normalized SIs of Meningioma and Ki-67 Expression
T1 m T 1 m/wm FLAIR m FLAIR m/wm T1 pc m T1 pc m/wm T1 pc/T1 native
Ki-67 % r = −0.9
P = − .489
r = −0.186
P = .152
r = −0.48
P = .723
r = 0.002
P = .991
r = −0.99
P = .439
r = −0.109
P = .396
r = 0.029
P = .827
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